Mometasone Furoate
Product Images NDC 51672-1311

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mometasone Furoate (NDC 51672-1311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mometasone 01)

Chemical structure diagram of the active ingredient in Mometasone Furoate, showing its steroid backbone with attached chlorine and furoate functional groups.*

FDA Label Image

Principal Display Panel (45 g Tube Label)

Label of Mometasone Furoate Ointment USP 0.1%, topical dermatologic ointment in a 45 g tube. Manufactured by Taro Pharmaceuticals Inc. in Brampton, Ontario, Canada, and distributed by Taro Pharmaceuticals U.S.A., Inc. Includes usage cautions, storage instructions, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.